Sheldon Krimsky
Datos Biográficos
| ID | 103708 |
|---|---|
| NOMBRE | Sheldon Krimsky |
| NOMBRES | Sheldon |
| APELLIDO | Krimsky |
| FIRMA | KRIMSKY S |
| AFILIACIONES | Tufts University |
| ORCID | 0000-0002-0647-9951 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 35 |
| TOTAL DE CITAS | 77 |
| TOTAL COMO AUTOR | 37 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 1979 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2021 |
| ÍNDICE H | 6 |
Glyphosate-Based Herbicides and Public Health
Conflicts of Interest In Science
An Illusory Consensus behind GMO Health Assessment
Prominent scientists and policymakers assert with confidence that there is no scientific controversy over the health effects of genetically modified organisms (GMOs)-that genetically modified crops currently in commercial use and those yet to be commercialized are inherently safe for human consumption and do not have to be tested. Those who disagree are cast as "GMO deniers." This article examines scientific reviews and papers on GMOs, compares t…
Do Financial Conflicts of Interest Bias Research
In the mid-1980s, social scientists compared outcome measures of related drug studies, some funded by private companies and others by nonprofit organizations or government agencies. The concept of a "funding effect" was coined when it was discovered that study outcomes could be statistically correlated with funding sources, largely in drug safety and efficacy studies. Also identified in tobacco research and chemical toxicity studies, the "funding…
Technocapitalism
Science in the private interest
Part 1 Foreword Chapter 2 Introduction Chapter 3 Stories of the Unholy Alliance Chapter 4 University-Industry Collaborations Chapter 5 Knowledge as Property Chapter 6 The Changing Ethos of Science Chapter 7 The Redemption of Federal Advisory Committees Chapter 8 Professors Incorporated Chapter 9 Conflicts of Interest Chapter 10 A Question of Bias Chapter 11 The Scientific Journals Chapter 12 The Demise of Public Science Chapter 13 Prospects for a…
Bingham Et Al. Respond
Judging by his simplified summary of what he believes to be the aims of the Daubert v Merrell Dow Pharmaceuticals, Inc, decision, Gori appears to have misunderstood much of what was presented in the July supplement to the Journal. Scientific reasoning is no more amenable to a mechanical approach than is legal reasoning. Daubert imposes unreachable objectives on judges: to separate science from nonscience and good science from bad science. Many of…
Autonomy, disinterest, and entrepreneurial science
From Asilomar to industrial biotechnology
Pacific Grove, California, set in motion the first scientific evaluation of genetically modi-fied organisms. It left a legacy that remains influential decades later when the world is faced with the prospect of a cornucopia of new products derived from gene-splicing tech-nology. Unlike the initial concerns over the risks of recombinant-DNA molecule technol-ogy (r-DNA), which was the centrepiece of the early controversy during and for several years…
The Weight of Scientific Evidence in Policy and Law
The term “weight of evidence” (WOE) appears in regulatory rules and decisions. However, there has been little discussion about the meaning, variations of use, and epistemic significance of WOE for setting health and safety standards. This article gives an overview of the role of WOE in regulatory science, discusses alternative views about the methodology underlying the concept, and places WOE in the context of the Supreme Court’s decision in Daub…
Science in the Private Interest
When Money Talks and Science Listens
Implicit precaution, scientific inference, and indirect evidence
In this study, we explore how the US Environmental Protection Agency (EPA) uses science in its overseeing of genetically modified (GM) plants producing their own pesticides (plant-incorporated protectants or PIPs). Our analysis is based on a systematic review of EPA's product assessments, regulatory decisions and policy documents on GM plants. In regulating PIPs, product characteristics remain the fundamental basis for the agency's risk assessmen…
Implicit precaution, scientific inference, and indirect evidence
Biotechnology at the Dinner Table
The U.S. Food and Drug Administration (FDA), which has statutory authority for protecting the safety and quality of the food supply, provides the oversight for genetically modified foods cultivated and marketed within the American agricultural system. This article examines the FDA's policies on genetically modified foods including its voluntary consultation program and its proposed rule on premarket notification and data submission. The FDA's con…
Agricultural Biotechnology and the Environment
Sociology
The Business of Research
The report of the Human Embryo Research Panel issued in September. 1994 comes in the aftermath of legislation - the National Institutes of Health (NIH) Revitalization Act of 1993 - that put an end to an eighteen - year de facto moratorium on embryo research in the United States. We are troubled by a number of aspects of the report, especially by (1) the fact that the proposed guidelines apply only to government-sponsored research and leave the fo…
Embryo Research Revisited
letter and replies
Gene mapping
The Rhetoric of Scientific Revolution
book review of THE HUMAN GENOME PROJECT by Thomas F. Lee and BIOTECHNICS AND SOCIETY by Sheldon Krimsky
Academic-Corporate Ties in Biotechnology
The rapid commercialization of applied genetics in the mtd-1970s, accompanied by a sudden rise in academic-corporate partnerships, raised questions about the impacts these linkages have had on the social and professional norms of scientists. The extent and pattern of faculty tnvolvement in commercialization of biological research is largely an unexplored area. This article provcdes a quantitative assessment of the linkages between biology faculty…
Science, Biopolitics and Risk
comment
Carrying the Baconian Torch
Book reviewed in this article: Controlling Life: Jacques Loeb and the Engineering Ideal in Biology. By Philip J. Pauly
Science and Politics in Transition
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content
Technocapitalism
Do Financial Conflicts of Interest Bias Research
In the mid-1980s, social scientists compared outcome measures of related drug studies, some funded by private companies and others by nonprofit organizations or government agencies. The concept of a "funding effect" was coined when it was discovered that study outcomes could be statistically correlated with funding sources, largely in drug safety and efficacy studies. Also identified in tobacco research and chemical toxicity studies, the "funding…
From Asilomar to industrial biotechnology
Pacific Grove, California, set in motion the first scientific evaluation of genetically modi-fied organisms. It left a legacy that remains influential decades later when the world is faced with the prospect of a cornucopia of new products derived from gene-splicing tech-nology. Unlike the initial concerns over the risks of recombinant-DNA molecule technol-ogy (r-DNA), which was the centrepiece of the early controversy during and for several years…
Academic-Corporate Ties in Biotechnology
The rapid commercialization of applied genetics in the mtd-1970s, accompanied by a sudden rise in academic-corporate partnerships, raised questions about the impacts these linkages have had on the social and professional norms of scientists. The extent and pattern of faculty tnvolvement in commercialization of biological research is largely an unexplored area. This article provcdes a quantitative assessment of the linkages between biology faculty…
Epistemic Considerations on the Value of Folk-wisdom in Science and Technology
Genetic Alchemy
An Illusory Consensus behind GMO Health Assessment
Prominent scientists and policymakers assert with confidence that there is no scientific controversy over the health effects of genetically modified organisms (GMOs)-that genetically modified crops currently in commercial use and those yet to be commercialized are inherently safe for human consumption and do not have to be tested. Those who disagree are cast as "GMO deniers." This article examines scientific reviews and papers on GMOs, compares t…
The Weight of Scientific Evidence in Policy and Law
The term “weight of evidence” (WOE) appears in regulatory rules and decisions. However, there has been little discussion about the meaning, variations of use, and epistemic significance of WOE for setting health and safety standards. This article gives an overview of the role of WOE in regulatory science, discusses alternative views about the methodology underlying the concept, and places WOE in the context of the Supreme Court’s decision in Daub…
Research under Community Standards
Glyphosate-Based Herbicides and Public Health
Gene mapping
Pure Science and Impure Scientists
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content
Recombinant DNA research
The paper provides an overview of public policy issues pertaining to the use of gene-splicing (recombinant DNA [deoxyribonucleic acid]) techniques in research and for industrial applications. Included is a discussion of the regulatory framework at the federal and institutional levels. The principal limitation of the current federal guidelines is its failure to provide mandatory coverage for private sector activities. Four municipalities and two s…
Recombinant DNA research
The paper provides an overview of public policy issues pertaining to the use of gene-splicing (recombinant DNA [deoxyribonucleic acid]) techniques in research and for industrial applications. Included is a discussion of the regulatory framework at the federal and institutional levels. The principal limitation of the current federal guidelines is its failure to provide mandatory coverage for private sector activities. Four municipalities and two s…
Genetic alchemy
Beyond Technocracy
Science Perverted
Book reviewed in this article: Politics and the Restraint of Science. By Leonard A. Cole
Genetic Alchemy
Responses & Reconsiderations
Pure Science and Impure Scientists
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content
Genetic Alchemy
Prometheus Entangled
Epistemic Considerations on the Value of Folk-wisdom in Science and Technology
Genetic Alchemy, the Social History of the Recombinant DNA Controversy
Genetic Alchemy summarizes and clarifies the background of policy and ethical issues, the debates engendered by uncertain risks to researchers and the population at large, and the roles played by scientists involved in one of the most prominent and controversial new technologies, gene splicing. The author, Assistant Professor of Urban and Environmental Policy at Tufts University, brings to the topic his experience on the Cambridge Review Board as…
Research under Community Standards
Science and Politics in Transition
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content
Carrying the Baconian Torch
Book reviewed in this article: Controlling Life: Jacques Loeb and the Engineering Ideal in Biology. By Philip J. Pauly
Science, Biopolitics and Risk
comment
Academic-Corporate Ties in Biotechnology
The rapid commercialization of applied genetics in the mtd-1970s, accompanied by a sudden rise in academic-corporate partnerships, raised questions about the impacts these linkages have had on the social and professional norms of scientists. The extent and pattern of faculty tnvolvement in commercialization of biological research is largely an unexplored area. This article provcdes a quantitative assessment of the linkages between biology faculty…
The Rhetoric of Scientific Revolution
book review of THE HUMAN GENOME PROJECT by Thomas F. Lee and BIOTECHNICS AND SOCIETY by Sheldon Krimsky
Gene mapping
The Business of Research
The report of the Human Embryo Research Panel issued in September. 1994 comes in the aftermath of legislation - the National Institutes of Health (NIH) Revitalization Act of 1993 - that put an end to an eighteen - year de facto moratorium on embryo research in the United States. We are troubled by a number of aspects of the report, especially by (1) the fact that the proposed guidelines apply only to government-sponsored research and leave the fo…
Embryo Research Revisited
letter and replies
Sociology
Agricultural Biotechnology and the Environment
Biotechnology at the Dinner Table
The U.S. Food and Drug Administration (FDA), which has statutory authority for protecting the safety and quality of the food supply, provides the oversight for genetically modified foods cultivated and marketed within the American agricultural system. This article examines the FDA's policies on genetically modified foods including its voluntary consultation program and its proposed rule on premarket notification and data submission. The FDA's con…
Implicit precaution, scientific inference, and indirect evidence
In this study, we explore how the US Environmental Protection Agency (EPA) uses science in its overseeing of genetically modified (GM) plants producing their own pesticides (plant-incorporated protectants or PIPs). Our analysis is based on a systematic review of EPA's product assessments, regulatory decisions and policy documents on GM plants. In regulating PIPs, product characteristics remain the fundamental basis for the agency's risk assessmen…
Implicit precaution, scientific inference, and indirect evidence
Political science (22 obras) · Law (15 obras) · Biology (14 obras) · Sociology (10 obras) · Biotechnology (9 obras) · Business (9 obras) · Genetically Modified Organisms Research (9 obras) · Computer Science (8 obras) · Philosophy (8 obras) · Biotechnology and Related Fields (7 obras)